Diffuse palmoplantar keratoderma, Bothnian type

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2337OMIM:600231Q82.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Diffuse palmoplantar keratoderma, Bothnian type (also known as Bothnia-type PPK or keratoderma palmoplantaris diffusa, Bothnian type) is a rare inherited skin disorder characterized by diffuse thickening of the skin on the palms of the hands and soles of the feet (palmoplantar keratoderma). The condition was first described in families from the Bothnian region of northern Sweden. It is caused by mutations in the AQP5 gene, which encodes aquaporin 5, a water channel protein important for sweat gland function and skin hydration. The keratoderma typically presents in early childhood and is notable for a distinctive spongy, white appearance of the thickened skin, particularly when exposed to water or moisture (a feature sometimes described as 'transgrediens' or wet-spongy pattern). The skin thickening is generally symmetric and can cause discomfort, difficulty with manual tasks, and impaired quality of life. The condition primarily affects the integumentary system (skin), specifically the palms and soles, though the thickened skin may occasionally extend beyond these areas onto the dorsal surfaces of the hands and feet. Hyperhidrosis (excessive sweating) of the palms and soles is a commonly associated feature, which may exacerbate the spongy white appearance of the affected skin. There is no cure for Bothnian-type palmoplantar keratoderma. Treatment is symptomatic and supportive, focusing on regular use of emollients, keratolytic agents (such as urea-based or salicylic acid-based creams) to reduce skin thickness, and careful foot care to prevent secondary complications such as fungal infections. In some cases, mechanical debridement of thickened skin may be helpful. Genetic counseling is recommended for affected families.

Also known as:

Clinical phenotype terms— hover any for plain English:

Diffuse palmoplantar hyperkeratosisHP:0007447Chronic tinea infectionHP:0032259Knuckle padHP:0032541Ridged nailHP:0001807
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Diffuse palmoplantar keratoderma, Bothnian type.

View clinical trials →

No actively recruiting trials found for Diffuse palmoplantar keratoderma, Bothnian type at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Diffuse palmoplantar keratoderma, Bothnian type community →

No specialists are currently listed for Diffuse palmoplantar keratoderma, Bothnian type.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Diffuse palmoplantar keratoderma, Bothnian type.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Diffuse palmoplantar keratoderma, Bothnian typeForum →

No community posts yet. Be the first to share your experience with Diffuse palmoplantar keratoderma, Bothnian type.

Start the conversation →

Latest news about Diffuse palmoplantar keratoderma, Bothnian type

No recent news articles for Diffuse palmoplantar keratoderma, Bothnian type.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Diffuse palmoplantar keratoderma, Bothnian type

What is Diffuse palmoplantar keratoderma, Bothnian type?

Diffuse palmoplantar keratoderma, Bothnian type (also known as Bothnia-type PPK or keratoderma palmoplantaris diffusa, Bothnian type) is a rare inherited skin disorder characterized by diffuse thickening of the skin on the palms of the hands and soles of the feet (palmoplantar keratoderma). The condition was first described in families from the Bothnian region of northern Sweden. It is caused by mutations in the AQP5 gene, which encodes aquaporin 5, a water channel protein important for sweat gland function and skin hydration. The keratoderma typically presents in early childhood and is notabl

How is Diffuse palmoplantar keratoderma, Bothnian type inherited?

Diffuse palmoplantar keratoderma, Bothnian type follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Diffuse palmoplantar keratoderma, Bothnian type typically begin?

Typical onset of Diffuse palmoplantar keratoderma, Bothnian type is childhood. Age of onset can vary across affected individuals.